— Seattle vaccine maker Curevo Vaccine hired Guy De La Rosa as its new chief medical officer. De La Rosa was previously an executive director at Enanta Pharmaceuticals, where he… Read More
The finalists for Deal of the Year at the 2023 GeekWire Awards all struck big transactions to help fuel their companies focused on cancer therapies, gaming, clean energy, data analytics,… Read More
— Amazon has promoted two executives to senior vice president: James Hamilton, a distinguished engineer at the company; and Drew Herdener, who leads worldwide communications. Both were previously vice presidents… Read More
Two COVID-19 vaccines developed in Seattle got the nod from regulatory agencies outside the U.S. this week. A University of Washington shot is ready for rollout in South Korea, and… Read More
Philip Greenberg has been trying to stop cancer for decades. With Affini-T Therapeutics, the Fred Hutchinson Cancer Research Center investigator may finally have his chance. The company announced $175 million… Read More
When Juno Therapeutics launched in 2013, cell therapy was a nascent field. Early clinical studies were showing dramatic rates of remissions in leukemia patients treated with their own immune cells,… Read More
A new cell therapy company is on the block, propelled by powerhouse scientific co-founders from Fred Hutchinson Cancer Research Center with years of experience investigating how to harness the immune… Read More